RFK Promotes Activist Who Called Mifepristone ‘High-Risk’ as FDA Weighs Restrictions
Media Mentions RFK Promotes Activist Who Called Mifepristone ‘High-Risk’ as FDA Weighs Restrictions November 10, 2026 Share https://www.autonomynews.co/rfk-promotes-anti-activist-natalie-dodson-who-called-mifepristone-high-risk-fda-drug-review/#new_tab Click to print Print Icon Share this page via E


